Agios Pharmaceuticals
AGIO
#5185
Rank
S$2.13 B
Marketcap
S$35.90
Share price
-2.50%
Change (1 day)
-7.72%
Change (1 year)

Operating Margin for Agios Pharmaceuticals (AGIO)

Operating Margin as of May 2026 (TTM): -719.97%

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -719.97%. At the end of 2024 the company had an Operating Margin of 1,967.15%.

Operating Margin history for Agios Pharmaceuticals from 2012 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
20241,967.15%-249.86%
2023-1,312.63%-19.36%
2022-1,627.82%
2018-366.61%-49.89%
2017-731.60%157.64%
2016-283.97%42.59%
2015-199.14%141.34%
2014-82.51%-45.71%
2013-151.98%66.43%
2012-91.32%20.86%
2011-75.56%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-101.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
43.07%-105.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
22.66%-103.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-82.45%-88.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
42.23%-105.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
11.89%-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.